Quality & complianceOfficial

Denmark flags supply problems for Amoxival Vet. 200 mg amoxicillin tablets from Ceva

🇩🇰 DKMA · Thu 05 Nov 2026

DKMA says production problems at Ceva Animal Health A/S are disrupting supply of the 10-tablet pack, with availability expected to be affected from early November to early December 2026.

The Danish Medicines Agency (DKMA) has published a supply notice for Amoxival Vet. 200 mg tablets in packs of 10, a veterinary medicine marketed by Ceva Animal Health A/S. The notice, dated 5 November 2026, states that there are current problems with supply of the product.

The active substance is amoxicillin, and the product carries the ATC vet code QJ01CA04. DKMA gives the cause as production problems and lists the expected period of disruption as the start of November to the start of December 2026.

The notice does not name alternative products or set out any recommended measures for prescribers. It also does not say how many packs are affected or whether other strengths or pack sizes are involved. DKMA directs anyone with questions about the current status to contact the company, and points readers to its page of notices on medicine supply.

As general context, national medicines agencies publish such notices to give prescribers, wholesalers and pharmacies advance warning of expected shortages.

What it means for your team

  • Veterinary prescribers and dispensers in Denmark should note the expected disruption window of early November to early December 2026 when planning amoxicillin treatment.
  • Supply-chain and market-access teams should treat the notice as covering only the 10-tablet pack of the 200 mg strength; no other presentations are mentioned.
  • DKMA names production problems as the cause and refers status queries to Ceva Animal Health A/S, so updates are likely to come from the company.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.

More Quality & compliance All →